Stock Movers Novo Plunges, Beazley Gains, Carlsberg Rises
Feb 4, 2026
Coverage of a surprise forecast from a major pharma firm that sent its shares tumbling. Discussion of a heated price war reshaping obesity drug competition. Report on a record-high insurer rally after a sweetened takeover proposal. A brewer boosts profit outlook while navigating shifting consumer tastes.
AI Snips
Chapters
Transcript
Episode notes
Novo Nordisk Faces Intensifying Price Pressure
- Novo Nordisk warned sales could fall as much as 13% this year, surprising investors and sparking an 18% share drop.
- Louise Moon links the decline to intensifying price competition, government pressure and cheaper copycat drugs eroding market share.
Beazley Agrees To Generous Zurich Bid
- Beazley accepted a sweetened £8 billion takeover from Zurich after a year of offers and rejections.
- Louise Moon says the agreed price represents a roughly 60% premium and pushed Beazley shares to record highs.
Deal Lifts Insurance Sector Sentiment
- The combined Zurich-Beazley entity will have about $15 billion of gross written premiums and be UK-based.
- Beazley's takeover talk lifted other insurers like Hiscox and Zurich on sector optimism.